BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1527 related articles for article (PubMed ID: 32679188)

  • 1. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
    Jiang Y; Zhan H
    Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG3 in Tumor Resistance to Therapy.
    De Marco M; Turco MC; Marzullo L
    Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR.
    Mohammad IS; He W; Yin L
    Crit Rev Ther Drug Carrier Syst; 2020; 37(5):473-509. PubMed ID: 33389848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
    Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
    Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
    Mao Z; Wu Y; Zhou J; Xing C
    Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of tumour microenvironment in the progression and development of oral cancer.
    Mughees M; Sengupta A; Khowal S; Wajid S
    Mol Biol Rep; 2021 Feb; 48(2):1773-1786. PubMed ID: 33492572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
    Saxena M; Stephens MA; Pathak H; Rangarajan A
    Cell Death Dis; 2011 Jul; 2(7):e179. PubMed ID: 21734725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
    Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
    J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
    Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
    Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chemosensitizing Role of Metformin in Anti-Cancer Therapy.
    Tang Z; Tang N; Jiang S; Bai Y; Guan C; Zhang W; Fan S; Huang Y; Lin H; Ying Y
    Anticancer Agents Med Chem; 2021; 21(8):949-962. PubMed ID: 32951587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
    Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.